Myelosuppression caused by nanoparticle albumin-bound paclitaxel in the Northern Chinese population and the role of body composition.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2259
Abstract: To examine the relationship between lean body mass (LBM) and the incidence and severity of neutropenia in patients with malignant tumors from Northern China who have received nanoparticle albumin-bound paclitaxel. Twenty-six patients with pathologically confirmed… read more here.
Keywords: albumin bound; incidence; group; bound paclitaxel ... See more keywords
Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-017-3385-7
Abstract: PurposeThis multicenter, single-arm, open-label, phase 2 study assessed the efficacy and safety of carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer, selected based on the Mini… read more here.
Keywords: plus weekly; nanoparticle albumin; bound paclitaxel; cancer ... See more keywords
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-019-03887-2
Abstract: Gastric cancer (GC) is the third cause of cancer-related death worldwide. Patients with unresectable GC can be treated with chemotherapy such as paclitaxel, which is a microtubule stabilizer. The use of nanoparticle albumin-bound paclitaxel (nab-ptx)… read more here.
Keywords: nanoparticle albumin; gastric cancer; bound paclitaxel; cancer ... See more keywords
S-1 and oxaliplatin combined with nanoparticle albumin-bound paclitaxel adjuvant chemotherapy for advanced gastric adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000002003
Abstract: To the Editor: Gastric cancer (GC) is the fi fth most common malignancy and the third most common cause of cancer-related death worldwide, with > 70% cases occurring in Asian populations. [1 read more here.
Keywords: albumin bound; combined nanoparticle; oxaliplatin combined; paclitaxel adjuvant ... See more keywords
Efficacy of albumin-bound paclitaxel combined with nedaplatin in neoadjuvant therapy for esophageal squamous cell carcinoma: A single-center retrospective observational study
Sign Up to like & getrecommendations! Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000033157
Abstract: This study was designed to observe the efficacy and safety of albumin-bound paclitaxel plus nedaplatin as neoadjuvant therapy in patients with esophageal squamous cell carcinoma (ESCC). From April 2019 to Dec 2020, patients with ESCC… read more here.
Keywords: albumin bound; neoadjuvant therapy; paclitaxel combined; combined nedaplatin ... See more keywords
SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Biological Sciences"
DOI: 10.7150/ijbs.64752
Abstract: Pancreatic cancer is a dismal malignancy with poor prognosis. In spite of progress in surgical technology, chemotherapy is still the cornerstone in the multi-disciplinary treatment. Albumin-bound paclitaxel is a first-line treatment for PDAC patients. Yet… read more here.
Keywords: albumin bound; sox8; expression; bound paclitaxel ... See more keywords